NCT06555263
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06555263
Title Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sutro Biopharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Health - Moores Cancer Center La Jolla California 92037 United States Details
Georgetown University Medical Center - Lombardi Comprehensive Cancer Center Washington D.C. District of Columbia 20057 United States Details
Florida Cancer Specialists & Research Institute (FCS) Lake Mary Florida 32746 United States Details
Tampa General Hospital - Cancer Center of South Florida Tampa Florida 33606 United States Details
HealthPartners Frauenshuh Cancer Center Saint Louis Park Minnesota 55426 United States Details
HealthPartners Cancer Center at Regions Hospital Saint Paul Minnesota 55101 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field